Guidelines for Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Guidelines for Authors

Pharmaceutical Technology

Pharmaceutical Technology and Pharmaceutical Technology Europe magazines welcome manuscripts on subjects pertinent to all aspects of drug development. See the following PDFs for more information on article contributions.

Pharmaceutical Technology North America

Guidelines for Authors

Guidelines for Supplements

Guidelines for Sourcing and Management eNewsletter

2014 Editorial Calendar

Pharmaceutical Technology Europe

Guidelines for Authors

2014 Editorial Calendar


Pharm Tech Talk

We also welcome contributed posts on our blog, PharmTech Talk, and encourage readers to leave comments. For information on blogging for PharmTech Talk, contact Rita Peters, the Editorial Director.

If you have any questions, please Contact the Editors.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here